首次出版:最新修訂:March 2009交付方式:特快專遞(2-3天送達(dá))
報(bào)告屬性:共323頁下載目錄 版權(quán)聲明
定購電話:0755-82571522、82571566、400-008-1522
24小時服務(wù)熱線:138 0270 8576 定制報(bào)告
版本 | 在線版 | 電子版+印刷版 | 在線報(bào)告庫(超1000份報(bào)告)全庫 |
---|---|---|---|
優(yōu)惠價 | RMB 6800 | RMB 7800 | RMB 9800 |
原價 | RMB 9600 | RMB 9800 | - |
聯(lián)系電話: 400 008 0586; 0755-82571568
微信掃碼:
1.EXECUTIVESUMMARY
·Introduction
ExecutiveSummary
2.GLOSSARYOFTERMSANDRESEARCHMETHODOLOGY
·ListofTerms
Definitions
·ResearchMethodology
ResearchMethodologyfortheEuropeanProstateCancerTherapeuticsMarket
3.EUROPEANPROSTATECANCERTHERAPEUTICSMARKET
·Introduction
DiseaseOverviewandClassificationSystems
PrevalenceandIncidence
TreatmentOptions
IdentificationofKeyUnmetNeeds
ScopeandSegmentation
MarketOverview
·MarketEngineeringResearch
MarketEngineeringMeasurements
IndustryChallenges
MarketDrivers
MarketRestraints
TotalRevenueForecasts
TrendsbyGeographicRegion
TrendsbySegment
CompetitiveAnalysis
4.SEGMENT-WISEANALYSIS
·LHRHAnalogs
MarketOverview
MarketEngineeringMeasurements
RevenueForecasts
CompetitiveStructure
AnalysisofKeyBrands
·Anti-androgens
MarketOverview
MarketEngineeringMeasurements
RevenueForecasts
CompetitiveStructure
AnalysisofKeyBrands
5.OPPORTUNITIESBYGEOGRAPHICREGION
·OpportunitiesinFrance
MarketOverview
MarketEngineeringMeasurements
RevenueForecasts
·OpportunitiesinGermany
MarketOverview
MarketEngineeringMeasurements
RevenueForecasts
·OpportunitiesinItaly
MarketOverview
MarketEngineeringMeasurements
RevenueForecasts
·OpportunitiesinSpain
MarketOverview
MarketEngineeringMeasurements
RevenueForecasts
·OpportunitiesintheUnitedKingdom
MarketOverview
MarketEngineeringMeasurements
RevenueForecasts
6.PIPELINEANALYSIS
·PipelineAnalysis
oKeyProductsinthePipeline
7.DATABASEOFKEYINDUSTRYPARTICIPANTS
·DKIPs
oListofMarketParticipants
8.DECISIONSUPPORTDATABASES
·DSDTables
CancerIncidence
ProstateCancerIncidence
MalePopulationAbove65YearsofAge
NumberofHospitals
NumberofPhysicians
This research service provides a detailed description of the European prostate cancer therapeutics market with emphasis on hormonal therapies.